Skip to content

Depression: all studies

Page 801 of 1,034: studies 8,001 to 8,010 of 10,336, newest first. Back to the depression overview

Research

Measuring psychological mechanisms in meditation practice: Using a phenomenologically grounded classification system to develop theory-based composite scores

April 13, 2021 Marco Schlosser, Thorsten Barnhofer, Florence Requier et al. 2 citations

Objectives: Deepening our understanding of the mechanisms by which meditation practices impact well-being and human flourishing is essential for advancing the science of meditation. The phenomenologically grounded classification system introduced by Dahl, Lutz, and Davidson (2015) distinguishes attentional, constructive, and deconstructive forms of meditation based on the psychological...

Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence

medRxiv Preprint Server April 10, 2021 Agnes Norbury, Sarah B. Rutter, Abigail B. Collins et al. 1 citation preprint

Promising initial data indicate that the glutamate N-methyl-D-aspartate (NMDA) receptor antagonist ketamine may be beneficial in post-traumatic stress disorder (PTSD). Here, we explore the neural correlates of ketamine-related changes in PTSD symptoms, using a rich battery of functional imaging data (two emotion-processing tasks and one task-free scan), collected from a subset of participants...

Psychedelic drug research will increase globally

Emerald Expert Briefings April 9, 2021

Significance: Government authorities, including in the United States, are speeding up licensing for clinical trials of these controlled drugs. Substantial philanthropic funding supports psychedelic medicine and campaigns for regulated use of these drugs, including for treatment of PTSD, chronic depression and addiction. Impacts: Biotechnology companies expect psychedelic therapies to become...

Taking the body off the mind: Decreased functional connectivity between somatomotor and default‐mode networks following Floatation‐REST

Human Brain Mapping April 9, 2021 Obada Al Zoubi, Masaya Misaki, Jerzy Bodurka et al. 39 citations

Abstract Floatation‐Reduced Environmental Stimulation Therapy (REST) is a procedure that reduces stimulation of the human nervous system by minimizing sensory signals from visual, auditory, olfactory, gustatory, thermal, tactile, vestibular, gravitational, and proprioceptive channels, in addition to minimizing musculoskeletal movement and speech. Initial research has found that Floatation‐REST...

DOI: 10.1002/hbm.25429 (opens in new tab) Default mode network Resting State FMRI Sensory stimulation therapy Neuroimaging +1

Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

ACS Pharmacology & Translational Science April 9, 2021 Gabrielle Agin-Liebes, Trevor F Haas, Rafael Lancelotta et al. 121 citations

Mescaline is a naturally occurring psychoactive alkaloid that has been used as a sacrament by Indigenous populations in spiritual ritual and healing ceremonies for millennia. Despite promising early preliminary research and favorable anecdotal reports, there is limited research investigating mescaline's psychotherapeutic potential. We administered an anonymous online questionnaire to adults (N...

Psilocybin and MDMA for the treatment of trauma-related psychopathology

International Review of Psychiatry April 3, 2021 Catherine Bird, Nadav L. Modlin, James J. H. Rucker 78 citations

This review examines the role of trauma in psychiatric morbidity and analogous psychoneurobiological changes. Trauma is a necessary criterion for Post-Traumatic Stress Disorder (PTSD), however, trauma history is highly correlated with a variety of psychiatric conditions. Some evidence suggests that Major Depressive Disorder (MDD) is the most common psychiatric condition that arises following...

Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)

April 2, 2021 Katharina Dworatzyk, Tallulah Jansen, Timo Torsten Schmidt 3 citations preprint

Several measures have been designed to assess subjective experiences induced by psychedelic substances and other mind-altering drugs or non-pharmacological methods. Recently, two self-report questionnaires have been introduced to measure acute adverse effects following psilocybin ingestion and the phenomenon of ego-dissolution associated with psychedelic use, respectively. The 26-item...

DOI: 10.31234/osf.io/kxmgq (opens in new tab) Full text (opens in new tab) Anxiety Confirmatory factor analysis Exploratory factor analysis Construct validity +9

Enhancing Cognition in Older Persons: A Pilot Clinical Trial of Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS)

Biological Psychiatry April 1, 2021 Heather J. Brooks, H. Oughli, Lojine Y. Kamel et al.

Introduction Low-burden and accessible interventions are needed to prevent cognitive decline in individuals at high-risk for decline. Mindfulness-Based Stress Reduction (MBSR) and transcranial direct current stimulation (tDCS) are two interventions which can be delivered remotely, improving their reach and scalability. This aim of this study is to assess the feasibility, safety and tolerability...

Treating with esketamine nasal, will increase blood pressure?

European Psychiatry April 1, 2021 V. Rosello-Molina, F.J. Castells Pons, V. Avellon Juarez et al.

Introduction Esketamine had been rised as a potential treatment for Resistant Depression, becoming an alternative for the use of Electroconvulsive Therapy. In Spain since 2020, it has been applied for compassionate use but is not widely used. Although Esketamine is defined safe and effective in preliminary studies, there are common side effects which could reduce it use. Objectives Increasing...

Is ketamine and lamotrigine interactions responsible for the sub-therapeutic effect of ketamine?

European Psychiatry April 1, 2021 Mahwish Adnan, F. Motiwala, Zeeshan Mansuri et al.

Introduction The immediate antidepressant effect of Ketamine has become a breakthrough in the treatment of depression. Cytochrome CYP3A4 and 2B6 primarily metabolize Ketamine. Objectives The present study explores potential pharmacokinetic and pharmacodynamic interactions of Lamotrigine and Ketamine. Methods A literature search was conducted using (“ketamine” OR “Lamotrigine” AND Interactions...